About Tergene Biotech
Tergene Biotech is a company based in Hyderabad (India) founded in 2008 was acquired by Aurobindo Pharma in February 2025.. Tergene Biotech operates in a competitive market with competitors including Biological E, Insmed, Affinivax, Altimmune and Eligo Bioscience, among others.
- Headquarter Hyderabad, India
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Tergene Biotech Limited
- Date of Incorporation 07 Mar, 2008
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$778.5 K (USD)107.03as on Mar 31, 2023
-
Net Profit
$-659.37 K (USD)20.31as on Mar 31, 2023
-
EBITDA
$-1.02 M (USD)-43.79as on Mar 31, 2023
-
Latest Funding Round
-
Investors
Aurobindo Pharma
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Aurobindo Pharma
(Feb 26, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Tergene Biotech
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2013 | Amount | Grant - Tergene Biotech | Valuation |
investors |
|
| Jun, 2012 | Amount | Grant - Tergene Biotech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tergene Biotech
Tergene Biotech has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Aurobindo Pharma, Department of Biotechnology and BIRAC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Business incubation services are provided across multiple sectors.
|
Founded Year | Domain | Location | |
|
Biotechnology research, guidelines, and funding by the Government of India.
|
Founded Year | Domain | Location | |
|
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tergene Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tergene Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tergene Biotech Comparisons
Competitors of Tergene Biotech
Tergene Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological E, Insmed, Affinivax, Altimmune and Eligo Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule inhibitors for rare lung diseases
|
|
| domain | founded_year | HQ Location |
Technology-based conjugate vaccines against infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
In vivo gene editing technology is developed for microbiome modulation.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for treating multiple infectious diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tergene Biotech
Frequently Asked Questions about Tergene Biotech
When was Tergene Biotech founded?
Tergene Biotech was founded in 2008 and raised its 1st funding round 4 years after it was founded.
Where is Tergene Biotech located?
Tergene Biotech is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
What is the annual revenue of Tergene Biotech?
Annual revenue of Tergene Biotech is $778.5K as on Mar 31, 2023.
What does Tergene Biotech do?
Tergene is developing bio-conjugate platform technologies for novel vaccines and antibody drug conjugates. It has developed technologies for the production of various vaccines and biosimilars such as Acellular Pertussis (ACP) vaccine, Haemophilus influenza type B (HiB) conjugated vaccine, Typhoid Vaccine, Streptokinase, Terinase - a thrombolytic enzyme are some of its developed technologies. The vaccines are currently under advanced stage of development include a multivalent pneumococcal vaccine and Meningococcal vaccine. It also offers a full range of contract research services from bioprocess development to manufacturing to approval of the finished product.
Who are the top competitors of Tergene Biotech?
Tergene Biotech's top competitors include Biological E, Insmed and Vaxart.
Who are Tergene Biotech's investors?
Tergene Biotech has 3 investors. Key investors include Aurobindo Pharma, Department of Biotechnology, and BIRAC.